The European Medicines Agency approves the WHO dose recommendations for anti-tuberculosis medicines used in children: ethambutol (MYAMBUTOL), isoniazid (NICOTIBINE), pyrazinamide (TEBRAZID) and rifampicin (RIFADINE). The FAMHP will take steps to ensure that the summary of product characteristics and the patient leaflet of these medicines are adapted according to these recommendations.
More information on the EMA website.
Contact
vig@fagg-afmps.be